4moving
Developer of a first-in-class disease-modifying osteoarthritis drug (DMOAD) for knee osteoarthritis
Country
Founded Date
2020
Headquarters
Industry
Latest Funding Round Date
February 10, 2026
Latest Funding Round Amount (USD)
14,300,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
14,300,000
Official Website
Find more companies like 4moving
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
